Acea Biosciences

IP Roundup

Premium

Yale University, University of South Florida, Alabama State University, Stanford University, SRU Biosystems, Eppendorf Array Technology, Agilent Technologies, Acea Biosciences

The new label-free and real-time cell-based assays will incorporate Vivo's HuBiogel platform.

The firms are developing a system for the early and accurate prediction of cardiotoxic side effects in the drug discovery process.

The US Environmental Protection Agency this week presented for the first time initial data from the first phase of its ToxCast program during the Society of Toxicology's annual meeting, held this year in Baltimore, according to an official from a company who participated in the p

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.